SB-200646

SB-200646
Clinical data
ATC code	none;
Legal status
Legal status	UN: Unscheduled ;
Identifiers
	IUPAC name 1-(1-Methyl-1H-indol-5-yl)-3-pyridin-3-ylurea;
PubChem CID	126769;
ChemSpider	112592;
KEGG	C11739;
ChEBI	CHEBI:8976;
ChEMBL	ChEMBL85194;
CompTox Dashboard (EPA)	DTXSID40162550 ;
Chemical and physical data
Formula	C15H14N4O
Molar mass	302.76 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Cn1ccc2c1ccc(c2)NC(=O)Nc3cccnc3;
	InChI InChI=1S/C15H14N4O/c1-19-8-6-11-9-12(4-5-14(11)19)17-15(20)18-13-3-2-7-16-10-13/h2-10H,1H3,(H2,17,18,20); Key:OJZZJTLBYXHUSJ-UHFFFAOYSA-N;

SB-200646 is a 5-HT₂ receptor antagonist with anxiolytic properties in rats. It was the first 5-HT₂ antagonist discovered to have selectivity of 5-HT_2C/_2B over 5-HT_2A.[1]

References

Kennett, GA; Wood, MD; Glen, A; Grewal, S; Forbes, I; Gadre, A; Blackburn, TP (1994), "In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist", Br J Pharmacol, British Journal of Pharmacology, 111: 797–802, doi:10.1111/j.1476-5381.1994.tb14808.x, PMC 1910094, PMID 7912626

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Kennett, GA; Wood, MD; Glen, A; Grewal, S; Forbes, I; Gadre, A; Blackburn, TP (1994), "In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist", Br J Pharmacol, British Journal of Pharmacology, 111: 797–802, doi:10.1111/j.1476-5381.1994.tb14808.x, PMC 1910094, PMID 7912626